Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
Completed
Teva Pharmaceuticals USA
Phase 1/Phase 2
2002-01-01
The purpose of this study was to demonstrate comparable efficacy, safety, and tolerability of
Teva Pharmaceuticals USA's generic formulation of Metronidazole Vaginal Gel, 0.75% and 3M
Pharmaceuticals' MetroGel-Vaginal® metronidazole vaginal gel, 0.75% to establish clinical
equivalence in the treatment of bacterial vaginosis.
Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects
Completed
Teva Pharmaceuticals USA
Phase 1
2001-11-01
The primary object of this study was to evaluate the relative bioavailability of the test
formulation of metronidazole vaginal gel with the already marketed reference formulation
MetroGel-Vaginal Gel® in healthy adult female subjects.
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
Terminated
Parexel
Phase 2
2015-04-01
THE STUDY HAS BEEN DESIGNED TO COMPARE THE EFFICACY OF TWO DOSES (25 MG AND 100 MG) OF
RIFAXIMIN VAGINAL TABLETS VERSUS PLACEBO IN SUBJECTS WITH BACTERIAL VAGINOSIS
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
Terminated
Alfa Wassermann S.p.A.
Phase 2
2015-04-01
THE STUDY HAS BEEN DESIGNED TO COMPARE THE EFFICACY OF TWO DOSES (25 MG AND 100 MG) OF
RIFAXIMIN VAGINAL TABLETS VERSUS PLACEBO IN SUBJECTS WITH BACTERIAL VAGINOSIS
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
Terminated
Alfasigma S.p.A.
Phase 2
2015-04-01
THE STUDY HAS BEEN DESIGNED TO COMPARE THE EFFICACY OF TWO DOSES (25 MG AND 100 MG) OF
RIFAXIMIN VAGINAL TABLETS VERSUS PLACEBO IN SUBJECTS WITH BACTERIAL VAGINOSIS
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
